HIV Archive

  • A key issue in the development of novel HIV drugs is their ability to inhibit the replication of genetically diverse isolates, especially those isolates from the most globally prevalent subtypes,...

    New MA/p17 matrix protein inhibitors display broad antiviral activity against multiple subtypes of HIV-1

    A key issue in the development of novel HIV drugs is their ability to inhibit the replication of genetically diverse isolates, especially those isolates from the most globally prevalent subtypes,...

    Continue Reading...

  • Moscow, October, 20 2008 Quantum and University of Pittsburgh announced a drug discovery collaboration in HIV sphere. Under the terms of agreement Quantum gets access to the target data from...

    Quantum collaborates with University of Pittsburgh on HIV drug discovery.

    Moscow, October, 20 2008 Quantum and University of Pittsburgh announced a drug discovery collaboration in HIV sphere. Under the terms of agreement Quantum gets access to the target data from...

    Continue Reading...

  • Moscow, September, 28 2006 Quantum Pharmaceuticals and A.N. Belozersky Institute of Physico-Chemical Biology entered drug discovery collaboration aimed to discovery of novel small molecule inhibitors of HIV-1 integrase. HIV-1 integrase...

    HIV-1 integrase drug discovery collaboration

    Moscow, September, 28 2006 Quantum Pharmaceuticals and A.N. Belozersky Institute of Physico-Chemical Biology entered drug discovery collaboration aimed to discovery of novel small molecule inhibitors of HIV-1 integrase. HIV-1 integrase...

    Continue Reading...

Get Adobe Flash playerPlugin by wpburn.com wordpress themes